SupplyLogic

After executing hundreds of transactions across market cycles, experienced M&A professionals develop sophisticated pattern recognition—the ability to quickly assess whether a target's EBITDA margins signal operational excellence or accounting engineering, whether management's integration plan is realistic or aspirational, whether projected synergies reflect disciplined bottom-up analysis or wishful thinking. This hard-won judgment remains invaluable, yet even the most seasoned investment bankers and corporate development executives now confront a reality that challenges traditional approaches: data volumes have exploded beyond human processing capacity, deal timelines have compressed to windows that preclude thorough manual analysis, and competitive dynamics increasingly favor firms that combine human expertise with machine intelligence. The question is no longer whether to integrate AI into M&A workflows, but how to deploy it in ways that genuinely amplify professional...

Investment banks are racing to implement generative AI across their operations, from equity research automation to risk assessment enhancement. Yet the majority of these Enterprise GenAI Deployment initiatives stumble not due to technological limitations, but because of fundamental strategic and organizational missteps. Having observed dozens of implementations across bulge bracket firms and boutique advisories, a clear pattern emerges: the same seven mistakes recur with alarming frequency, each one capable of derailing months of effort and millions in investment. Understanding these pitfalls before you encounter them can mean the difference between a transformative deployment and a costly false start. The stakes for getting Enterprise GenAI Deployment right have never been higher. As regulatory scrutiny intensifies and clients demand faster, more sophisticated analyses, the banks that successfully integrate generative AI into their core workflows—from IPO bookbuilding to derivatives ...